Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic

BACKGROUND: Poor antipsychotic (AP) adherence is a key issue in patients with schizophrenia. First-generation antipsychotic (FGA) and second-generation antipsychotic (SGA) long-acting injectable therapies (LAI) may improve adherence compared to oral antipsychotics (OAP). The objective of the study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilon, Dominic, Joshi, Kruti, Tandon, Neeta, Lafeuille, Marie-Hélène, Kamstra, Rhiannon L, Emond, Bruno, Lefebvre, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367457/
https://www.ncbi.nlm.nih.gov/pubmed/28356723
http://dx.doi.org/10.2147/PPA.S127623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367457/
https://www.ncbi.nlm.nih.gov/pubmed/28356723
http://dx.doi.org/10.2147/PPA.S127623

Ejemplares similares